Cargando…
Tu1258: EFFECTIVENESS OF COVID-19 VIRAL VECTOR JANSSEN AD.26.COV2.S VACCINE AND COMPARISON WITH MRNA VACCINES IN CIRRHOSIS
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AGA Institute. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212545/ http://dx.doi.org/10.1016/S0016-5085(22)63679-5 |
| _version_ | 1784730622364745728 |
|---|---|
| author | John, Binu V. Doshi, Akash Deng, Yangyang Mansour, Natalie Barritt, Alfred Sidney Moon, Andrew M. Ioannou, George N. Martin, Paul Chao, Hann-Hsiang Taddei, Tamar H. Kaplan, David E. Dahman, Bassam |
| author_facet | John, Binu V. Doshi, Akash Deng, Yangyang Mansour, Natalie Barritt, Alfred Sidney Moon, Andrew M. Ioannou, George N. Martin, Paul Chao, Hann-Hsiang Taddei, Tamar H. Kaplan, David E. Dahman, Bassam |
| author_sort | John, Binu V. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9212545 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AGA Institute. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92125452022-06-22 Tu1258: EFFECTIVENESS OF COVID-19 VIRAL VECTOR JANSSEN AD.26.COV2.S VACCINE AND COMPARISON WITH MRNA VACCINES IN CIRRHOSIS John, Binu V. Doshi, Akash Deng, Yangyang Mansour, Natalie Barritt, Alfred Sidney Moon, Andrew M. Ioannou, George N. Martin, Paul Chao, Hann-Hsiang Taddei, Tamar H. Kaplan, David E. Dahman, Bassam Gastroenterology AASLD Abstracts AGA Institute. Published by Elsevier Inc. 2022-05 2022-06-16 /pmc/articles/PMC9212545/ http://dx.doi.org/10.1016/S0016-5085(22)63679-5 Text en Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | AASLD Abstracts John, Binu V. Doshi, Akash Deng, Yangyang Mansour, Natalie Barritt, Alfred Sidney Moon, Andrew M. Ioannou, George N. Martin, Paul Chao, Hann-Hsiang Taddei, Tamar H. Kaplan, David E. Dahman, Bassam Tu1258: EFFECTIVENESS OF COVID-19 VIRAL VECTOR JANSSEN AD.26.COV2.S VACCINE AND COMPARISON WITH MRNA VACCINES IN CIRRHOSIS |
| title | Tu1258: EFFECTIVENESS OF COVID-19 VIRAL VECTOR JANSSEN AD.26.COV2.S VACCINE AND COMPARISON WITH MRNA VACCINES IN CIRRHOSIS |
| title_full | Tu1258: EFFECTIVENESS OF COVID-19 VIRAL VECTOR JANSSEN AD.26.COV2.S VACCINE AND COMPARISON WITH MRNA VACCINES IN CIRRHOSIS |
| title_fullStr | Tu1258: EFFECTIVENESS OF COVID-19 VIRAL VECTOR JANSSEN AD.26.COV2.S VACCINE AND COMPARISON WITH MRNA VACCINES IN CIRRHOSIS |
| title_full_unstemmed | Tu1258: EFFECTIVENESS OF COVID-19 VIRAL VECTOR JANSSEN AD.26.COV2.S VACCINE AND COMPARISON WITH MRNA VACCINES IN CIRRHOSIS |
| title_short | Tu1258: EFFECTIVENESS OF COVID-19 VIRAL VECTOR JANSSEN AD.26.COV2.S VACCINE AND COMPARISON WITH MRNA VACCINES IN CIRRHOSIS |
| title_sort | tu1258: effectiveness of covid-19 viral vector janssen ad.26.cov2.s vaccine and comparison with mrna vaccines in cirrhosis |
| topic | AASLD Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212545/ http://dx.doi.org/10.1016/S0016-5085(22)63679-5 |
| work_keys_str_mv | AT johnbinuv tu1258effectivenessofcovid19viralvectorjanssenad26cov2svaccineandcomparisonwithmrnavaccinesincirrhosis AT doshiakash tu1258effectivenessofcovid19viralvectorjanssenad26cov2svaccineandcomparisonwithmrnavaccinesincirrhosis AT dengyangyang tu1258effectivenessofcovid19viralvectorjanssenad26cov2svaccineandcomparisonwithmrnavaccinesincirrhosis AT mansournatalie tu1258effectivenessofcovid19viralvectorjanssenad26cov2svaccineandcomparisonwithmrnavaccinesincirrhosis AT barrittalfredsidney tu1258effectivenessofcovid19viralvectorjanssenad26cov2svaccineandcomparisonwithmrnavaccinesincirrhosis AT moonandrewm tu1258effectivenessofcovid19viralvectorjanssenad26cov2svaccineandcomparisonwithmrnavaccinesincirrhosis AT ioannougeorgen tu1258effectivenessofcovid19viralvectorjanssenad26cov2svaccineandcomparisonwithmrnavaccinesincirrhosis AT martinpaul tu1258effectivenessofcovid19viralvectorjanssenad26cov2svaccineandcomparisonwithmrnavaccinesincirrhosis AT chaohannhsiang tu1258effectivenessofcovid19viralvectorjanssenad26cov2svaccineandcomparisonwithmrnavaccinesincirrhosis AT taddeitamarh tu1258effectivenessofcovid19viralvectorjanssenad26cov2svaccineandcomparisonwithmrnavaccinesincirrhosis AT kaplandavide tu1258effectivenessofcovid19viralvectorjanssenad26cov2svaccineandcomparisonwithmrnavaccinesincirrhosis AT dahmanbassam tu1258effectivenessofcovid19viralvectorjanssenad26cov2svaccineandcomparisonwithmrnavaccinesincirrhosis |